EyePoint, Inc. business relationships
Companies named in EyePoint, Inc.’s 10-K filed 2026-03-05, and public companies whose annual reports name EyePoint, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.0 / 10
- AI naming
- <1 / 100 Top 55% in its category
- Agent readiness
- 5 / 100
- AI adoption
- 0 / 100
Named in EyePoint, Inc.’s annual report 3
“the success of current and future license and collaboration agreements, including our agreements with ANI Pharmaceuticals, Inc. (ANI), Equinox Science, LLC (Equinox), and Ocumension Therapeutics (Ocumension);” SEC filing
“On May 2, 2022, the Company entered into an Exclusive License Agreement (the Betta License Agreement) with Betta Pharmaceuticals Co., Ltd. (Betta), an affiliate of Equinox.” SEC filing
“C ommercial Supply Agreement, dated May 17, 2023, by and between EyePoint, Inc. and Alimera Sciences, Inc.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.